Very excited to share that our work on Parkinson's target USP30 has been published in Nature Structural & Molecular Biology! By combining soluble DUB-domains onto USP30, we for the first time achieved co-crystallization with a small molecule (NK036) without Nanobodies!
www.nature.com/articles/s41...
Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of the mitophagy regulator USP30 - Nature Structural & Molecular Biology
Kazi et al. report the crystal structure of the mitochondrial deubiquitinase USP, a clinical stage Parkinson’s disease drug target, in complex with a specific inhibitor. The authors delineate a framew...
